Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Actuate Therapeutics Inc.
Brigham and Women's Hospital
Seagen Inc.
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
HealthPartners Institute
UNC Lineberger Comprehensive Cancer Center
Brigham and Women's Hospital
Mayo Clinic
Seagen Inc.
Incyte Corporation
City of Hope Medical Center
Bayer
Tempus AI
Pfizer
British Columbia Cancer Agency
University of California, Irvine
Tongji Hospital
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhejiang Provincial People's Hospital
Columbia University
Exelixis
Spectrum Pharmaceuticals, Inc
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
Fondazione per la Medicina Personalizzata
pharmaand GmbH
Hoffmann-La Roche
OncoNano Medicine, Inc.
Jules Bordet Institute
Karolinska University Hospital
Ambrx, Inc.
Main Line Health
University of Kansas Medical Center
ExcellaBio LLC
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)